8-K Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 7, 2020

Period of Report

April 5, 2020

Accession Number

0000930413-20-000983

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →